Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Valero

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Seminars in Oncology|May 5, 1998
Future direction of neoadjuvant therapy for breast cancerV Valero
Oncology (Williston Park, N.Y.)|August 1, 1997
Combination docetaxel/cyclophosphamide in patients with advanced solid tumorsV Valero
Anti-Cancer Drugs|August 1, 1996
Treatment of patients resistant to paclitaxel therapyV Valero
Oncology (Williston Park, N.Y.)|June 1, 1997
Docetaxel and cyclophosphamide in patients with advanced solid tumorsV Valero
Seminars in Oncology|August 1, 1997
Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacyV Valero
Annals of Emergency Medicine|January 1, 1986
Mesenteric laceration complicating a Heimlich maneuverV Valero
Revista De Salud Publica (Bogota, Colombia)|February 3, 2007
Malaria in Colombia: retrospective glance during the past 40 yearsMaría V Valero-Bernal
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Primary chemotherapy: a better overall therapeutic option for patients with breast cancerV Valero, G N Hortobagyi
Seminars in Oncology|April 1, 1995
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancerP M Ravdin, V Valero
Seminars in Oncology|September 12, 2001
Doxorubicin and taxane combination regimens for metastatic breast cancer: focus on cardiac effectsV Valero, E Perez, V Dieras
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|May 5, 1998
Future direction of neoadjuvant therapy for breast cancerV Valero
Oncology (Williston Park, N.Y.)|August 1, 1997
Combination docetaxel/cyclophosphamide in patients with advanced solid tumorsV Valero
Anti-Cancer Drugs|August 1, 1996
Treatment of patients resistant to paclitaxel therapyV Valero
Oncology (Williston Park, N.Y.)|June 1, 1997
Docetaxel and cyclophosphamide in patients with advanced solid tumorsV Valero
Seminars in Oncology|August 1, 1997
Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacyV Valero
Annals of Emergency Medicine|January 1, 1986
Mesenteric laceration complicating a Heimlich maneuverV Valero
Revista De Salud Publica (Bogota, Colombia)|February 3, 2007
Malaria in Colombia: retrospective glance during the past 40 yearsMaría V Valero-Bernal
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Primary chemotherapy: a better overall therapeutic option for patients with breast cancerV Valero, G N Hortobagyi
Seminars in Oncology|April 1, 1995
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancerP M Ravdin, V Valero
Seminars in Oncology|September 12, 2001
Doxorubicin and taxane combination regimens for metastatic breast cancer: focus on cardiac effectsV Valero, E Perez, V Dieras
Pageof 12